296 related articles for article (PubMed ID: 19712815)
1. Value of MRCP using oral Gd-DTPA as negative contrast materials in diagnosis of atypical juxtapapillary duodenal diverticulum.
Gong J; Zhao H; Liu T; Ling R; Xu J
Clin Imaging; 2009; 33(5):361-4. PubMed ID: 19712815
[TBL] [Abstract][Full Text] [Related]
2. Juxtapapillary diverticulum: findings on MRI.
Balci NC; Noone T; Akün E; Akinci A; Klör HU
J Magn Reson Imaging; 2003 Apr; 17(4):487-92. PubMed ID: 12655590
[TBL] [Abstract][Full Text] [Related]
3. Defining juxtapapillary diverticulum with 3D segmented trueFISP MRCP: comparison with conventional MRCP sequences with an oral negative contrast agent.
Morita S; Ueno E; Masukawa A; Suzuki K; Machida H; Fujimura M
Jpn J Radiol; 2009 Dec; 27(10):423-9. PubMed ID: 20035414
[TBL] [Abstract][Full Text] [Related]
4. Dilution method of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI).
Motosugi U; Ichikawa T; Sou H; Sano K; Ichikawa S; Tominaga L; Araki T
J Magn Reson Imaging; 2009 Oct; 30(4):849-54. PubMed ID: 19787734
[TBL] [Abstract][Full Text] [Related]
5. Focal pancreatitis mimicking pancreatic mass: magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP) findings including diffusion-weighted MRI.
Momtahen AJ; Balci NC; Alkaade S; Akduman EI; Burton FR
Acta Radiol; 2008 Jun; 49(5):490-7. PubMed ID: 18568532
[TBL] [Abstract][Full Text] [Related]
6. Detection of active bile leak with Gd-EOB-DTPA enhanced MR cholangiography: comparison of 20-25 min delayed and 60-180 min delayed images.
Cieszanowski A; Stadnik A; Lezak A; Maj E; Zieniewicz K; Rowinska-Berman K; Grudzinski IP; Krawczyk M; Rowiński O
Eur J Radiol; 2013 Dec; 82(12):2176-82. PubMed ID: 24012454
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.
Tamada T; Ito K; Sone T; Yamamoto A; Yoshida K; Kakuba K; Tanimoto D; Higashi H; Yamashita T
J Magn Reson Imaging; 2009 Mar; 29(3):636-40. PubMed ID: 19243060
[TBL] [Abstract][Full Text] [Related]
8. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
[TBL] [Abstract][Full Text] [Related]
9. Arterial visualization by contrast-enhanced moving-table MR angiography: crossover comparison of 0.1 and 0.2 mmol/kg doses of meglumine gadopentetate in normal volunteers.
Hayashi H; Yuasa Y; Amano Y; Tanimoto A; Saito Y; Yoshioka K; Kita M; Kumazaki T; Hiramatsu K
J Magn Reson Imaging; 2008 Sep; 28(3):783-90. PubMed ID: 18777556
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of gall bladder carcinoma with dynamic magnetic resonance imaging and magnetic resonance cholangiopancreatography.
Kaza RK; Gulati M; Wig JD; Chawla YK
Australas Radiol; 2006 Jun; 50(3):212-7. PubMed ID: 16732816
[TBL] [Abstract][Full Text] [Related]
11. Obliteration of the Biliary System after Administration of an Oral Contrast Medium Is Probably due to Regurgitation: A Pitfall on MRCP.
Sakamoto K; Shinagawa Y; Inoue K; Morita A; Urakawa H; Fujimitsu R; Takano K; Yoshimitsu K
Magn Reson Med Sci; 2016; 15(1):137-43. PubMed ID: 26346397
[TBL] [Abstract][Full Text] [Related]
12. MR cholangiopancreatography at 3.0 T: intraindividual comparative study with MR cholangiopancreatography at 1.5 T for clinical patients.
Onishi H; Kim T; Hori M; Murakami T; Tatsumi M; Nakaya Y; Nakamoto A; Osuga K; Tomoda K; Nakamura H
Invest Radiol; 2009 Sep; 44(9):559-65. PubMed ID: 19692840
[TBL] [Abstract][Full Text] [Related]
13. Suspected chronic pancreatitis with normal MRCP: findings on MRI in correlation with secretin MRCP.
Balci NC; Alkaade S; Magas L; Momtahen AJ; Burton FR
J Magn Reson Imaging; 2008 Jan; 27(1):125-31. PubMed ID: 18058927
[TBL] [Abstract][Full Text] [Related]
14. Balanced MR cholangiopancreatography with motion-sensitised driven-equilibrium (MSDE) preparation: feasibility of Gd-EOB-DTPA-enhanced biliary examination.
Nakayama T; Yoshiura T; Nishie A; Asayama Y; Ishigami K; Kakihara D; Takayama Y; Hatakenaka M; Obara M; Honda H
Clin Radiol; 2016 Dec; 71(12):1284-1288. PubMed ID: 27146898
[TBL] [Abstract][Full Text] [Related]
15. Human comparative study of zinc and copper excretion via urine after administration of magnetic resonance imaging contrast agents.
Kimura J; Ishiguchi T; Matsuda J; Ohno R; Nakamura A; Kamei S; Ohno K; Kawamura T; Murata K
Radiat Med; 2005 Aug; 23(5):322-6. PubMed ID: 16342903
[TBL] [Abstract][Full Text] [Related]
16. Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers.
Brismar TB; Dahlstrom N; Edsborg N; Persson A; Smedby O; Albiin N
Acta Radiol; 2009 Sep; 50(7):709-15. PubMed ID: 19701821
[TBL] [Abstract][Full Text] [Related]
17. [Oral ferric ammonium citrate solution in MRCP for diagnosing low-level obstructive jaundice].
Yang P; Zhang YD; Li NF; Li WZ; Zhou GF
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):347-50. PubMed ID: 17478951
[TBL] [Abstract][Full Text] [Related]
18. Initial experience on utility of gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted MR cholangiography in diagnosis of acute cholecystitis.
Akpinar E; Turkbey B; Karcaaltincaba M; Balli O; Akkapulu N; Balas S; Tirnaksiz B; Akata D; Akhan O
J Magn Reson Imaging; 2009 Sep; 30(3):578-85. PubMed ID: 19711404
[TBL] [Abstract][Full Text] [Related]
19. Targeted magnetic resonance imaging with intraperitoneal and intravenous streptavidin (SA)-DTPA-Gd: a comparative study in tumor-bearing nude mice.
Ye J; Xu YK; Liu X; Lü GS
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):139-43. PubMed ID: 16503514
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging of active sacroiliitis: do we really need gadolinium?
Althoff CE; Feist E; Burova E; Eshed I; Bollow M; Hamm B; Hermann KG
Eur J Radiol; 2009 Aug; 71(2):232-6. PubMed ID: 19446974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
